Abstract:Question Does the hypoxic hypobaric environment of a high altitude increase the risk of cardiac arrhythmia? Findings In this cohort study, more than 1 in 3 participants experienced bradyarrhythmia or tachyarrhythmia during the ascent from basecamp to the summit of Mount Everest. The proportion of individuals with arrhythmia remained stable across levels of increasing altitude, while the majority of arrhythmias occurred when no supplemental bottled oxygen was used. Meaning The potential implications of the observed rhythm disturbances at high altitudes need to be explored in future studies. Importance Arterial hypoxemia, electrolyte imbalances, and periodic breathing increase the vulnerability to cardiac arrhythmia at altitude. Objective To explore the incidence of tachyarrhythmias and bradyarrhythmias in healthy individuals at high altitudes. Design, Setting, and Participants This prospective cohort study involved healthy individuals at altitude (8849 m) on Mount Everest, Nepal. Recruitment occurred from January 25 to May 9, 2023, and data analysis took place from June to July 2023. Exposure All study participants underwent 12-lead electrocardiogram, transthoracic echocardiography, and exercise stress testing before and ambulatory rhythm recording both before and during the expedition. Main Outcome The incidence of a composite of supraventricular (>30 seconds) and ventricular (>3 beats) tachyarrhythmia and bradyarrhythmia (sinoatrial arrest, second- or third-degree atrioventricular block). Results Of the 41 individuals recruited, 100% were male, and the mean (SD) age was 33.6 (8.9) years. On baseline investigations, there were no signs of exertional ischemia, wall motion abnormality, or cardiac arrhythmia in any of the participants. Among 34 individuals reaching basecamp at 5300 m, 32 participants climbed to 7900 m or higher, and 14 reached the summit of Mount Everest. A total of 45 primary end point–relevant events were recorded in 13 individuals (38.2%). Forty-three bradyarrhythmic events were documented in 13 individuals (38.2%) and 2 ventricular tachycardias in 2 individuals (5.9%). Nine arrhythmias (20%) in 5 participants occurred when climbers were using supplemental bottled oxygen, whereas 36 events (80%) in 11 participants occurred at lower altitudes when no supplemental bottled oxygen was used. The proportion of individuals with arrhythmia remained stable across levels of increasing altitude, while event rates per 24 hours numerically increased between 5300 m (0.16 per 24 hours) and 7300 m (0.37 per 24 hours) before decreasing again at higher altitudes, where supplemental oxygen was used. None of the study participants reported dizziness or syncope. Conclusion and Relevance In this study, more than 1 in 3 healthy individuals experienced cardiac arrhythmia during the climb of Mount Everest, thereby confirming the association between exposure to high altitude and incidence of cardiac arrhythmia. Future studies should explore the potential implications of these rhythm disturbances.

Association between high cardiac output at altitude and acute mountain sickness: preliminary study on Mt. Fuji

Influence of Smoking and Alcohol Habits on Symptoms of Acute Mountain Sickness on Mount Fuji: A Questionnaire Survey-Based Pilot Study

Research advances in pathogenesis and prophylactic measures of acute high altitude illness

Altitude Cardiomyopathy Is Associated With Impaired Stress Electrocardiogram and Increased Circulating Inflammation Makers

High altitude exercise stress echocardiograph for identification of susceptibility to acute mountain sickness

Clinical and Pathophysiological Features of High-altitude Pulmonary Edema in the Japanese Population: A Review of Studies on High-altitude Pulmonary Edema in Japan

Risk of Cardiac Arrhythmias Among Climbers on Mount Everest

The role of hypoxia related hormones responses in acute mountain sickness susceptibility individuals unaccustomed to high altitude

Lung function parameters are associated with acute mountain sickness and are improved at high and extreme altitude

Temporal changes in biomarkers in individuals with and without acute mountain sickness following rapid ascent

Different Influencing Factors for Risk of Falls Between Men and Women while Descending from Mount Fuji

Acute mountain sickness on Jade Mountain: Results from the real-world practice (2018–2019)

Effect of acetazolamide and gingko biloba on the human pulmonary vascular response to an acute altitude ascent.

The changes of electroencephalography in mountaineers on Mount Jade, Taiwan: An observational study

The application of supine bicycle exercise stress echocardiograph for identification of susceptibility to acute mountain sickness

Altitude illnesses

Association of arterial oxygen saturation and acute mountain sickness susceptibility: a meta-analysis

Seasonal Effects of High-Altitude Forest Travel on Cardiovascular Function: An Overlooked Cardiovascular Risk of Forest Activity

Elevated sympathoadrenal response following active ascent to 3,600m is not associated with acute mountain sickness

Effects of short-term exposure to high altitude on cardiac function

Flying to high-altitude destinations: Is the risk of acute mountain sickness greater?